Organon & Co. (OGN)
13.90
0.00 (0.00%)
USD |
NYSE |
Nov 17, 16:00
13.90
0.00 (0.00%)
After-Hours: 20:00
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 3.650B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 83.47% |
| Valuation | |
| PE Ratio | 18.08 |
| PE Ratio (Forward) | |
| PS Ratio | 0.6073 |
| Price to Book Value | 3.060 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 0.02 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 7.170 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 82.70% |
Profile
| Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ. |
| URL | http://www.organon.com |
| Investor Relations URL | N/A |
| HQ State/Province | New Jersey |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Small Cap Value |
| Next Earnings Release | Feb. 11, 2027 (est.) |
| Last Earnings Release | Oct. 30, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Nov. 09, 2026 |
Profile
| Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ. |
| URL | http://www.organon.com |
| Investor Relations URL | N/A |
| HQ State/Province | New Jersey |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Small Cap Value |
| Next Earnings Release | Feb. 11, 2027 (est.) |
| Last Earnings Release | Oct. 30, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Nov. 09, 2026 |